XML 19 R39.htm IDEA: XBRL DOCUMENT

EQUITY (CAPITAL DEFICIENCY) (Tables)

6 Months Ended

Jun. 30, 2012

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Additional Information about Warrants and Share Options

	Outstanding as of June 30, 2012
Exercise price	Warrants and options outstanding		Weighted average remaining contractual life (years)		Warrants and options exercisable
0 - 0.004		976,535		4.72		925,809
0.732		51,253		3.41		51,253
0.752		83,637		3.73		83,636
2.92		126,250		9.92
3.16		97,500		9.97
3.2		75,000		9.9
3.96		146,090		5.76		146,089
4.92		862,583		4.59		737,681
6.00		784,808		3.79		679,839
6.9		3,652		6.5		3,652
7		20,290		3.92		6,764
7.2		188,179		4.2		188,179
7.72		53,750		3.94		16,667
7.8		836,750		9.38		120,833
8.00		10,000		4.18
8.4		2,500		9.5
10.00		125,000		9.04
10.4		1,250		3.98		416
		4,445,027		5.85		2,960,818

Schedule of Allocation of Share Based Compensation Expense

	6 months ended June 30, 2012		Year ended December 31
	6 months ended June 30, 2012		2011		2010		2009
	($ in thousands)
Revenue	$	68	$	-	$	-	$	-
Cost of revenues		35		350		160		49
Research and development		206		267		536		356
Sales and marketing		181		431		55		92
General and administrative		1,454		8,542		869		65
	$	1,944	$	9,590	$	1,620	$	562

Options and Warrants Granted to Employees [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Information about Warrants and Share Options

	6 month period ended June 30, 2012					Year Ended December 31,
	6 month period ended June 30, 2012					2011					2010					2009
	Number of warrants and options			Weighted average exercise price		Number of warrants and options			Weighted average exercise price		Number of warrants and options			Weighted average exercise price		Number of warrants and options			Weighted average exercise price
Outstanding - beginning of period		2,017,756		$	5.6		875,524		$	2.76		514,358		$	2.6		611,792		$	2.12
Granted*		333,750			3.56		1,573,104			7.68		446,385			2.48		56,813			3.16
Forfeited		(30,421	)		6.36		(180,872	)		6.72		(85,219	)		2.6		(39,566	)		3.4
Exercised		-			-		(250,000	)		6		-			-		(114,681	)		-
Outstanding - end of period		2,321,085			5.28		2,017,756		$	5.6		875,524		$	2.76		514,358		$	2.6
Exercisable at the end of the period		904,108		$	3.52		717,116		$	2.84		551,134		$	2.96		258,532		$	1.2

Including 140,000 and 362,500 options with performance conditions in the period ended June 30, 2012 and the year ended December 31, 2011, respectively. See Note 2m.

Schedule of Assumptions used to determine the Fair Value of Options

	6 months ended June 30, 2012			Year ended December 31
	6 months ended June 30, 2012			2011			2010			2009
Expected life		5.5 - 6.5 years			0.17 - 6.5 years			5.25 - 6 years			5.54 - 6 years
Risk-free interest rates		0.7% - 1.3	%		0.03% - 2.79	%		1.7% - 2.69	%		1.7% - 2.49	%
Volatility		58% - 66	%		55% - 79	%		79% - 80	%		75% - 79	%
Dividend yield		0	%		0	%		0	%		0	%

Options and Warrants Granted to Non Employees [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Information about Warrants and Share Options

	6 month period ended June 30, 2012					Year Ended December 31,
	6 month period ended June 30, 2012					2011					2010					2009
	Number of warrants and options			Weighted average exercise price		Number of warrants and options			Weighted average exercise price		Number of warrants and options			Weighted average exercise price		Number of warrants and options		Weighted average exercise price
Outstanding - beginning of period		2,100,507		$	3.92		1,174,402		$	1.56		934,978		$	0.8		845,536	$	0.4
Granted*		132,862			4.96		990,831			5.92		269,860			4.84		89,442		4.28
Forfeited		(109,427	)		2.36		(64,726	)		2.48		(30,436	)		-		-		-
Exercised		-			-		-			-		-			-		-		-
Outstanding - end of period		2,123,942		$	3.8		2,100,507		$	3.92		1,174,402		$	1.56		934,978	$	0.8
Exercisable at the end of the period		2,056,710		$	3.76		2,049,965		$	3.84		1,158,896		$	1.6		859,986	$	0.48

Including 19,479 and 24,349 options with performance conditions in the period ended June 30, 2012 and the year ended December 31, 2011, respectively. See Note 2m.

Schedule of Assumptions used to determine the Fair Value of Options

	6 month period ended June 30, 2012			Year ended December 31
	6 month period ended June 30, 2012			2011			2010			2009
Expected life		2 - 10 years			1 - 10 years			9.7 - 10 years			9 - 10 years
Risk-free interest rates		0.3% - 1.47	%		1.02% - 3.39	%		2.65% - 3.01	%		3.4% - 3.59	%
Volatility		47% - 65	%		53% - 62	%		87	%		86% - 91	%
Dividend yield		0	%		0	%		0	%		0	%

- Definition

Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.

+ References+ Details

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References+ Details